The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Glycoprotein 41 (gp41) - Drugs in Development, 2021
US$ 3,500.00
Glycoprotein 41 (gp41) - Drugs in Development, 2021 SUMMARY According to the recently published report 'Glycoprotein 41 - Drugs In Development, 2021'; Glycoprotein 41 (gp41) pipeline Target constitute...
September 2021
67 pages
Impetigo (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Impetigo (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Impetigo - Drugs In Development, 2021, provides a...
September 2021
45 pages
Malaria (Infectious Disease) - Drugs in Development, 2021
US$ 2,500.00
Malaria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria - Drugs In Development, 2021, provides an...
September 2021
450 pages
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Drugs In Development, 2021...
September 2021
88 pages
Peritonitis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Peritonitis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peritonitis - Drugs In Development, 2021, provid...
September 2021
53 pages
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021
US$ 2,000.00
Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia - Drugs In Development, 202...
September 2021
113 pages
Tularaemia (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Tularaemia (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Drugs In Development, 2021, provid...
September 2021
44 pages
Analgesics in Ukraine
US$ 990.00
In analgesics, demographic trends have a significant impact on retail sales in Ukraine. While the population is set to decrease further, as per ... into the growing incidence of age-related diseases a... Euromonitor International's Analgesics in Ukraine report offers a comprehensive guide to the size and shape of ...
September 2021
27 pages
Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine
US$ 990.00
... advertisements of cough, cold and allergy (hay fever) remedies on television (eg Ambrobene and Edem) also contribute to consumer awar... Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Ukraine report ...
September 2021
26 pages
Digestive Remedies in Ukraine
US$ 990.00
... the hands of the most recent c... Euromonitor International's Digestive Remedies in Ukraine report offers a comprehensive guide to the size and ... coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies. Data coverage: ...
September 2021
25 pages
NRT Smoking Cessation Aids in Ukraine
US$ 990.00
... so that already price-sensitive consumers will f... Euromonitor International's NRT Smoking Cessation Aids in Ukraine report offers a comprehensive guide to the size and shape ... this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving ...
September 2021
23 pages
NRT Smoking Cessation Aids in Egypt
US$ 990.00
... run campaigns to discourage smoking, and NRT smoking cessation aids are prohibited in the country. Some brands are available, however,... Euromonitor International's NRT Smoking Cessation Aids in Egypt report offers a comprehensive ...
September 2021
16 pages
Synthetic Vitamin E - A Global Market Overview
US$ 3,600.00
... .2 million. RESEARCH FINDINGS & COVERAGE Synthetic Vitamin E market is analyzed in this report ... Synthetic Vitamin E by a major geographic region Installed capacities of Synthetic Vitamin E manufacturers Supply Shortage of Vitamin E Spikes Prices Forcing Feed Manufacturers to Reduce the Usage Synthetic Vitamin ...
September 2021
192 pages
Research Report on China's Alectinib Market, 2021-2025
US$ 2,600.00
Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 4.57 million new cancer cases were reported in China in 2020, including 820,000 lung cancer cases. 3 million cance...
September 2021
40 pages
Research Report on China's Anastrozole Market, 2021-2025
US$ 2,600.00
According to IARC’s 2020 World Cancer Report, the number of new cases of breast cancer reached 2.26 million in 2020, larger than that of lung cancer cases which was 2.2 million. Breast cancer has beco...
September 2021
40 pages
Research Report on China's Escitalopram Market, 2021-2025
US$ 2,600.00
Depression is the fourth leading disease in the world and is expected to become the first by 2030. However, the medical prevention and treatment of depression in China is still of low recognition rate...
September 2021
40 pages
Research Report on China's Exemestane Market, 2021-2025
US$ 2,600.00
Breast cancer is a common malignant tumor in menopausal women, and now ranks first among malignant tumors in women. Recently, the number of breast cancer patients in China has been increasing year by...
September 2021
40 pages
Research Report on China's Gefitinib Market, 2021-2025
US$ 2,600.00
Lung cancer is the most common type of cancer and the leading cause of cancer deaths. 19.29 million new cancer cases were diagnosed worldwide in 2020, 4.57 million of which were in China, accounting f...
September 2021
40 pages
Research Report on China's Levetiracetam Market, 2021-2025
US$ 2,600.00
Epilepsy is second only to stroke as a common chronic neurological disorder characterized by excessive neuronal discharge in the brain resulting in recurrent, seizure and transient central nervous sys...
September 2021
40 pages
Research Report on China's Lobaplatin Market, 2021-2025
US$ 2,600.00
According to IARC of WHO, globally, there were 19.29 million new cases of cancer in 2020, among which 2.26 million were cases of breast cancer, surpassing the 2.2 million cases of lung cancer. Breast...
September 2021
40 pages
Research Report on China's Mesalazine Market, 2021-2025
US$ 2,600.00
Inflammatory bowel disease (IBD) is a chronic disease of the digestive system with unclear etiology, difficulty to cure, and recurrent attacks with multiple complications. The incidence of IBD in Chin...
September 2021
40 pages
Research Report on China's Roxatidine Market, 2021-2025
US$ 2,600.00
Peptic ulcers and gastrointestinal bleeding are common diseases in China with a large number of patients. Due to the fast pace of modern life, accelerated urbanization and great mental stress, the num...
September 2021
40 pages
Research Report on China's Sorafenib Market, 2021-2025
US$ 2,600.00
Hepatocellular carcinoma (HCC) is the most common type of chronic liver cancer in adults and the most common cause of death in patients with cirrhosis. Hepatocellular carcinoma (HCC) is the third most...
September 2021
40 pages
Research Report on China's Venlafaxine Market, 2021-2025
US$ 2,600.00
Depression is the result of a complex interplay of social, psychological and physical factors. People who experience adverse events in their lives are more likely to develop depression. Depression can...
September 2021
40 pages
